NASDAQ · TDAC

Translational Development Acquisition Corp.

$10.74 -$0.01 (-0.09%) 1D After hours
Charting by TradingView

Key Metrics

$207.47M
Market cap
—
P/E · TTM
—
Revenue · TTM
—
Net income
EPS · TTM —
Dividend yield —
Free cash flow —
Beta · 1Y 0.03
EBITDA · TTM —
Gross margin —

Snapshot

Market cap$207.47M
Enterprise value—
Shares outstanding19.3M
52-wk range$10.32 – $10.80
Avg volume · 20D205.8K
Net cash —
Book value / share—
IndustryBlank Checks
ExchangeNASDAQ
About Translational Development Acquisition Corp.
IPO dateFeb 13, 2025
Employees—

Translational Development Acquisition Corp is a newly organized blank check company.

Wolf Grade COMING SOON

—

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E—
P/S—
P/FCF—
EV/EBITDA—
EV/Sales—
Graham №—

Profitability

Gross —
Operating —
Net —
FCF —
ROE / ROIC — · —

Financial Health

Current ratio—
Quick ratio—
Debt / equity—
Debt / EBITDA —
Net cash —
Working capital—

Cash Flow · TTM

Operating CF —
Capex —
Free cash flow —
Buybacks —
Dividends paid —
Shareholder yield —

Piotroski F-Score

—
Needs two fiscal years of filings

Altman Z-Score

—
Insufficient balance-sheet inputs

Graham Number vs Price

—
Requires positive earnings and book value